248 related articles for article (PubMed ID: 8832524)
1. Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status.
Marcoullis G; Mehta J; Treleaven J
Med Oncol; 1995 Dec; 12(4):209-18. PubMed ID: 8832524
[TBL] [Abstract][Full Text] [Related]
2. The rationale of autologous bone marrow transplantation.
Mandelli F; Meloni G
Bone Marrow Transplant; 1991; 7 Suppl 2():66-7. PubMed ID: 1878725
[No Abstract] [Full Text] [Related]
3. High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies.
Blume KG; Forman SJ
Semin Oncol; 1992 Dec; 19(6 Suppl 13):63-6. PubMed ID: 1492228
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation in haematological malignancies. Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
Gahrton G; Gratwohl A; Ernst P; Hermans J; Lyklema A; Zwaan FE
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():4-6. PubMed ID: 2627623
[No Abstract] [Full Text] [Related]
5. Transplantation with blood stem cells.
Zander AR; Lyding J; Bielack S
Blood Cells; 1991; 17(2):301-9. PubMed ID: 1680500
[TBL] [Abstract][Full Text] [Related]
6. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
[TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow transplantation.
Kochupillai V; Kumar L; Anandhi R
Indian J Pathol Microbiol; 1991 Apr; 34(2):152-9. PubMed ID: 1752645
[No Abstract] [Full Text] [Related]
8. Autologous blood stem cell transplantation in hematologic malignancies.
Majolino I; Scimé R; Indovina A
Haematologica; 1990; 75(6):555-66. PubMed ID: 1983000
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow and peripheral blood hematopoietic stem cell transplantation: focus on autografting.
Baynes RD; Hamm C; Dansey R; Klein J; Cassells L; Karanes C; Abella E; Peters WP
Clin Chem; 2000 Aug; 46(8 Pt 2):1239-51. PubMed ID: 10926918
[TBL] [Abstract][Full Text] [Related]
10. [Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center].
Rio B; Marjanovic Z; Belhocine R; Vekhoff A; Andrieu V; Klaren J; Boccaccio C; Delmer A; Ajchenbaum-Cymbalista F; Hunault M; Bazarbachi A; Lévy V; Andreu G; Zittoun R
Ann Med Interne (Paris); 1996; 147(5):313-9. PubMed ID: 9033732
[TBL] [Abstract][Full Text] [Related]
11. Autotransplants in myeloma.
Barlogie B; Jagannath S
Bone Marrow Transplant; 1992; 10 Suppl 1():37-44. PubMed ID: 1355685
[No Abstract] [Full Text] [Related]
12. Etoposide in leukemia, lymphoma and bone marrow transplantation.
Stadtmauer EA; Cassileth PA; Gale RP
Leuk Res; 1989; 13(8):639-50. PubMed ID: 2677526
[TBL] [Abstract][Full Text] [Related]
13. The current status of hematopoietic stem cell transplantation for multiple myeloma.
Bensinger WI
Clin Adv Hematol Oncol; 2004 Jan; 2(1):46-52. PubMed ID: 16163159
[TBL] [Abstract][Full Text] [Related]
14. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
15. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
16. Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
Langenmayer I; Weaver C; Buckner CD; Lilleby K; Appelbaum FR; Longin K; Rowley S; Storb R; Singer J; Bensinger WI
Bone Marrow Transplant; 1995 Feb; 15(2):241-6. PubMed ID: 7773213
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors.
Kotasek D; Shepherd KM; Sage RE; Dale BM; Norman JE; Charles P; Gregg A; Pillow A; Bolton A
Bone Marrow Transplant; 1992 Jan; 9(1):11-7. PubMed ID: 1347478
[TBL] [Abstract][Full Text] [Related]
18. Heart rate variability and heart rate turbulence in patients with hematologic malignancies subjected to high-dose chemotherapy in the course of hematopoietic stem cell transplantation.
Poręba M; Poręba R; Gać P; Usnarska-Zubkiewicz L; Pilecki W; Piotrowicz E; Piotrowicz R; Rusiecki L; Kuliczkowski K; Mazur G; Sobieszczańska M
Ann Noninvasive Electrocardiol; 2014 Mar; 19(2):157-65. PubMed ID: 24206437
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis of hematological patients with relapse following high-dose chemotherapy and autologous stem cell transplantation].
Baggers J; Johnsen HE
Ugeskr Laeger; 1998 Sep; 160(38):5505-8. PubMed ID: 9763925
[TBL] [Abstract][Full Text] [Related]
20. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
